Aqr Capital Management LLC Harvard Bioscience Inc Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.0 - $5.82 $47,020 - $68,414	11,755 New	11,755 $50,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.42 $623,997 - $1.22 Million	-190,243 Reduced 84.7%	34,363 $124,000
Q1 2022 May 16, 2022	SELL	$5.16 - $7.14 $684,401 - $947,021	-132,636 Reduced 37.13%	224,606 $1.4 Million
Q4 2021 Feb 14, 2022	BUY	$6.37 - $8.18 $279,611 - $359,061	43,895 Added 14.01%	357,242 $2.52 Million
Q3 2021 Nov 15, 2021	BUY	$6.98 - $8.47 $2.02 Million - $2.45 Million	288,759 Added 1174.39%	313,347 $2.19 Million
Q2 2021 Aug 16, 2021	BUY	$5.44 - $8.4 $133,758 - $206,539	24,588 New	24,588 $205,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.